HCPCS Level II · Outpatient PPS (temporary codes)
C9045Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Terminated 09/30/2019
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9045
C9045 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, moxetumomab pasudotox-tdfk, 0.01 mg.
It was added to HCPCS effective 04/01/2019, and its current record took effect 10/01/2019.
It was terminated on 09/30/2019 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Moxetumomab pasudotox-tdfk
- Date added
- 04/01/2019
- Action effective
- 10/01/2019
- Termination date
- 09/30/2019
- BETOS
- O1D
Related C90xx codes
Common questions about C9045
Is HCPCS C9045 still valid?
- No. C9045 was terminated on 09/30/2019.
Does Medicare cover C9045?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.